First-in-human trial for regenerative cell therapy for sensorineural hearing loss approved
Rinri Therapeutics, a world leading spinout company from the University of ¾ÅÉ«ÊÓÆµ dedicated to transforming sensorineural hearing loss (SNHL) with regenerative cell therapy, has received approval to begin its first-in-human clinical trial.Â